| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 939 | 789 | 671 | 938 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 939 | 789 | 671 | 938 | | | Operating Expenses | | Research Development | 26,537 | 29,035 | 29,587 | 38,326 | | Selling General and Administrative | 5,966 | 4,491 | 5,330 | 5,506 | | Non Recurring |
-
|
-
|
-
| (227) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (31,564) | (32,737) | (34,246) | (42,667) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5,263) | (916) | 548 | 560 | | Earnings Before Interest And Taxes | (36,827) | (33,653) | (33,698) | (42,107) | | Interest Expense | 6,530 | 6,382 | 6,338 | 6,298 | | Income Before Tax | (43,357) | (40,035) | (40,036) | (48,405) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (43,357) | (40,035) | (40,036) | (48,405) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (43,357) | (40,035) | (40,036) | (48,405) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($43,357) | ($40,035) | ($40,036) | ($48,405) |
|
1.52% Nasdaq 
Income Statement
